NCT07584057 2026-05-13An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer CachexiaYunnan Baiyao Group Co., Ltd.Phase 1/2 Not yet recruiting146 enrolled